| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Dec 24 | RVNC Revance Therapeutics | Common Stock | Grant | Acquire A | No | No | 2.1845 | 1,000 | 2.18 k | 996,935 |
| 30 Jun 24 | RVNC Revance Therapeutics | Common Stock | Grant | Acquire A | No | No | 2.1845 | 1,000 | 2.18 k | 995,935 |
| 30 May 24 | GKOS Glaukos | Common Stock | Grant | Acquire A | No | No | 0 | 1,716 | 0.00 | 34,936 |
| 30 May 24 | GKOS Glaukos | Stock Option Common Stock | Grant | Acquire A | No | No | 110.7 | 1,246 | 137.93 k | 1,246 |
| 15 Mar 24 | RVNC Revance Therapeutics | Common Stock | Payment of exercise | Dispose F | No | No | 5.305 | 17,228 | 91.39 k | 994,935 |
| 15 Mar 24 | RVNC Revance Therapeutics | Common Stock | Payment of exercise | Dispose F | No | No | 5.305 | 3,305 | 17.53 k | 1,012,163 |
| 6 Mar 24 | RVNC Revance Therapeutics | Common Stock | Buy | Acquire P | No | No | 6.98 | 30,000 | 209.40 k | 1,015,468 |
